David Shapiro - CEO of B2i Digital
@b2idigital
B2i Digital is The Capital Markets Matchmaker℠, connecting investors and public companies through digital marketing, investor conferences, and direct meetings. b2idigital.com
You might also like
Ben 🏔️🏃♂️🇫🇷
@beninchamonix.eurosky.social
13 videos
مصدر عام | The Public Source
@thepublicsource
5 videos
Albert and Mary Lasker Foundation
@laskerfdn
6 videos
Libby Cudmore (SHE/HER)
@libbycudmore
11 videos
Josh is "here"
@realracingroots
5 videos
Joe Littrell
@gentlemanjoe
5 videos
Bryan Dawson
@bryandawsonusa
41 videos
advertiseagents. Nachrichtenagentur.
@advertiseagents
20 videos
Cavitation Technologies, Inc. (OTCQB: CVAT) presents at the Small Cap Growth Virtual Investor Conference at 12:30 PM ET on Thursday, June 4, 2026. The Small Cap Growth Virtual Investor Conference is a B2i Digital Featured Conference. For more details, please visit: b2idigital.com/vic-june4-sm...
Abingdon Health plc (OTCQB: ABDXF | LSE: ABDX) presents at the Small Cap Growth Virtual Investor Conference at 12:00 PM ET on Thursday, June 4, 2026. The Small Cap Growth Virtual Investor Conference is a B2i Digital Featured Conference. For more details, please visit: b2idigital.com/vic-june4-sm...
Corero Network Security plc (OTCQX: DDOSF | LSE: CNS) joins the Small Cap Growth Virtual Investor Conference at 9:30 AM ET on Thursday, June 4, 2026. The Small Cap Growth Virtual Investor Conference is a B2i Digital Featured Conference. For more details, please visit: b2idigital.com/vic-june4-sm...
Phio Pharmaceuticals (NASDAQ: PHIO) to present its INTASYL® siRNA platform and PH-762 program at the Renmark Live Virtual Non-Deal Roadshow on Thursday, May 28, 2026. See the company’s profile at b2idigital.com/phio-pharmac.... Disclosure: B2i Digital is not a broker-dealer or investment adviser.
ZenaTech (NASDAQ: ZENA) advances three ZenaDrone platforms into the cybersecurity phase of Blue UAS certification, moving toward U.S. defense procurement eligibility. A profile of ZenaTech will be added soon at b2idigital.com/featured-com... See the complete Disclosure at b2idigital.com/disclaimer
Jupiter Neurosciences (Nasdaq: JUNS) signs a term sheet valued at up to $100 million for exclusive, perpetual U.S. rights to ALA-002, a next-generation MDMA candidate from PharmAla Biotech. Jupiter Neurosciences is a B2i Digital Featured Company. See the full profile: b2idigital.com/jupiter-neur...
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) lifts borrowing base 15% to $75M, plans a $4M debt paydown this month, and reaffirms year-end net debt target of $25M to $30M. See the company’s profile at (b2idigital.com/kolibri-glob...) See the complete Disclosure at b2idigital.com/disclaimer
The B2i Digital team is pleased to announce Galantas Gold Corp. (OTCID: GALKF | TSXV: GAL) is participating in the Precious Metals & Critical Minerals Virtual Investor Conference (OTC Markets Group) on Wednesday, May 6, 2026 at 2:00 PM EDT. B2i Digital is not a broker-dealer or investment adviser.